Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04829058 · ClinicalTrials.gov registry record

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

A clinical trial of Pelvic Organ Prolapse, sponsored by Ethicon.

Recruiting
Registry status
100
Enrollment target
3
Study locations

NCT04829058 is a study of Pelvic Organ Prolapse that is actively recruiting participants, run by Ethicon. The registered enrollment target is 100 participants, below the 143-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (30% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04829058, a study of Pelvic Organ Prolapse, is actively recruiting participants, sponsored by Ethicon.

RECRUITING
Registry status
100 participants
Enrollment target
3
Study locations

Study Summary

The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse with a GYNEMESH PS Mesh.

Conditions Studied

Interventions

  • DEVICE Intervention

Study Locations (3)

Pennsylvania

  • Institute for Female Pelvic Medicine - North Wales
  • UMPC - Pittsburgh

Other

  • Universitatsklinikum Tubingen - Tübingen

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-11-24
Est. Completion 2032-03-31

Sponsor

Ethicon

38 total trials

What the Registry Record Tells You About NCT04829058

The ClinicalTrials.gov registry entry for NCT04829058 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 143-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (30% lower). The listed sponsor is Ethicon, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Intervention is the first listed.

NCT04829058 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Other.

Frequently Asked Questions

What is clinical trial NCT04829058 about?

NCT04829058 is a clinical study titled "GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study". The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse with a GYNEMESH PS Mesh.

What is the current status of trial NCT04829058?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2021-11-24. Estimated completion is 2032-03-31.

What conditions does trial NCT04829058 study?

This clinical trial studies the following conditions: Pelvic Organ Prolapse.

What interventions are being tested in trial NCT04829058?

The interventions under investigation include: Intervention (DEVICE).

Who is sponsoring clinical trial NCT04829058?

This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04829058 being conducted?

This trial has 3 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Organ Prolapse

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.